A study in the Journal of the American Heart Association showed significant cost savings when patients who are at risk for stroke due to atrial fibrillation undergo a one-time, minimally invasive procedure to implant the WATCHMAN™ Left Atrial Appendage Closure Device rather than receive lifelong anticoagulant treatment.